DekaBank Deutsche Girozentrale Invests $34,000 in Siga Technologies Inc. $SIGA

DekaBank Deutsche Girozentrale bought a new position in Siga Technologies Inc. (NASDAQ:SIGA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,160 shares of the company’s stock, valued at approximately $34,000.

Several other institutional investors and hedge funds also recently modified their holdings of SIGA. Russell Investments Group Ltd. boosted its position in shares of Siga Technologies by 6,344.8% in the first quarter. Russell Investments Group Ltd. now owns 9,925 shares of the company’s stock worth $54,000 after buying an additional 9,771 shares during the period. Corton Capital Inc. purchased a new stake in shares of Siga Technologies in the first quarter worth about $58,000. EP Wealth Advisors LLC boosted its position in shares of Siga Technologies by 44.1% in the first quarter. EP Wealth Advisors LLC now owns 20,018 shares of the company’s stock worth $110,000 after buying an additional 6,131 shares during the period. Cerity Partners LLC purchased a new stake in shares of Siga Technologies in the first quarter worth about $119,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in shares of Siga Technologies in the second quarter worth about $123,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

Siga Technologies Stock Down 0.1%

Shares of NASDAQ SIGA opened at $8.43 on Tuesday. The stock’s 50 day moving average price is $8.65 and its two-hundred day moving average price is $7.26. Siga Technologies Inc. has a 52-week low of $4.95 and a 52-week high of $9.62. The stock has a market capitalization of $603.67 million, a P/E ratio of 7.46 and a beta of 0.96.

Siga Technologies (NASDAQ:SIGA) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.49 earnings per share (EPS) for the quarter. Siga Technologies had a return on equity of 40.52% and a net margin of 45.73%.The firm had revenue of $81.12 million for the quarter. On average, analysts anticipate that Siga Technologies Inc. will post 1.04 EPS for the current year.

Analyst Upgrades and Downgrades

SIGA has been the subject of a number of analyst reports. Wall Street Zen raised Siga Technologies from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 9th. Weiss Ratings reissued a “hold (c)” rating on shares of Siga Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Siga Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.